People Background Check
Find People:

Daniel T Belmont, Age 67Petersburg, KY

Get Report
Known as:
Daniel Thomas Belmont Daniel P Belmont Daniel Bellmont

Daniel Belmont Phones & Addresses

Petersburg, KY

3297 Nicolette Dr, Howell, MI 48114 (517) 546-3821

3297 Nicolette Dr #98, Howell, MI 48843 (517) 546-3821

Newport, KY

1 Gershom Dr, North Grafton, MA 01536 (508) 293-1008 (774) 293-1008

2788 Kragspough Ct, Holland, MI 49424 (616) 394-4940

1241 Saint James Ct, Holland, MI 49424 (616) 786-2930

190 W Lakewood Blvd, Holland, MI 49424 (616) 394-4940

164 Sunset Dr, Holland, MI 49423 (616) 394-4940

1 Gershom Dr, North Grafton, MA 01536 (517) 546-3821

Show more

Work

Position: Personal Care and Service Occupations

Education

Degree: Bachelor's degree or higher

Mentions for Daniel T Belmont

Career records & work history

Medicine Doctors

Daniel Belmont

Specialties:
Emergency Medicine
Work:
Elmhurst Emergency Medical Services
155 E Brush Hl Rd, Elmhurst, IL 60126
(630) 833-1400 (phone) (331) 221-3777 (fax)
Education:
Medical School
Rosalind Franklin University/ Chicago Medical School
Graduated: 1998
Languages:
English, Spanish
Description:
Dr. Belmont graduated from the Rosalind Franklin University/ Chicago Medical School in 1998. He works in Elmhurst, IL and specializes in Emergency Medicine. Dr. Belmont is affiliated with Elmhurst Memorial Hospital.
Daniel Belmont Photo 1

Daniel M Belmont

Specialties:
Emergency Medicine
Education:
Rosalind Franklin University (1998)

Daniel Belmont resumes & CV records

Resumes

Daniel Belmont Photo 26

Student Intern

Work:

Student Intern
Daniel Belmont Photo 27

Daniel Belmont

Daniel Belmont Photo 28

Daniel Belmont

Daniel Belmont Photo 29

Daniel Belmont

Daniel Belmont Photo 30

Daniel Belmont

Location:
United States

Publications & IP owners

Us Patents

Process For Preparing Functionalized Γ-Butyrolactones From Mucohalic Acid

US Patent:
7071339, Jul 4, 2006
Filed:
Jun 18, 2003
Appl. No.:
10/463612
Inventors:
Daniel Belmont - Howell MI, US
Ji Zhang - Ann Arbor MI, US
Assignee:
Warner Lambert Company LLC - Morris Plains NJ
International Classification:
C07D 307/32
US Classification:
549323, 549324
Abstract:
A process for preparing functionalized γ-butyrolactones 3 and various biologically active compounds using mucohalic acid 1 and halide 2 in the presence of indium is disclosed, wherein X, Y, R, R, and Rmay have any of the meanings defined herein.

Preparation Of 4-Substituted-2-Buten-4-Olides From Mucohalic Acids

US Patent:
2006000, Jan 5, 2006
Filed:
Jun 28, 2005
Appl. No.:
11/168795
Inventors:
Paul Angell - Dexter MI, US
Daniel Belmont - Howell MI, US
Timothy Curran - Whitmore Lake MI, US
Ji Zhang - Ann Arbor MI, US
International Classification:
C07D 307/34
US Classification:
549313000
Abstract:
Methods and materials for preparing 4-substituted-2-buten-4-olides are disclosed. The method includes reacting a mucohalic acid with a silyl enol ether or a ketene silyl acetal in the presence of a Lewis acid.

Process Of Producing Cycloalkylcarboxamido-Indole Compounds

US Patent:
2013032, Dec 5, 2013
Filed:
Apr 21, 2011
Appl. No.:
13/642642
Inventors:
Daniel T. Belmont - Grafton MA, US
Cristian Harrison - Beverly MA, US
Robert Michael Hughes - San Diego CA, US
Young Chun Jung - Lexington MA, US
Elaine Chungmin Lee - Arlington MA, US
Benjamin Joseph Littler - Carlsbad CA, US
Peter Jamison Rose - Littleton MA, US
David Andrew Siesel - San Diego CA, US
Gerald J. Tanoury - Marlborough MA, US
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED - CAMBRIDGE MA
International Classification:
C07D 405/12
US Classification:
548454
Abstract:
The present invention features processes for preparing compounds, such as (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (Compound 1), useful for treating CFTR mediated diseases such as cystic fibrosis.

Process For The Preparation Of [1S-(1R*,2S*,3R*)]-N-(4-Morpholinylsulfonyl)-L-Phenylalanyl-3-(2-Amino-4 -Thiazolyl-N-[(1-Cyclohexylmethyl)-2,3-Dihydroxy-5-Methylhexyl]-L-Alanina Mide

US Patent:
5089616, Feb 18, 1992
Filed:
Apr 23, 1991
Appl. No.:
7/690012
Inventors:
Daniel T. Belmont - Holland MI
Valerie Hendrickson - Grandville MI
Mark J. Hoekman - Holland MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
C07D41712
US Classification:
544133
Abstract:
An improved process for the preparation of [1S-(1R*,2S*,3R*)]-N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-t hiazolyl)-N-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-alaninamid e is described where the key intermediate, 3-(2-amino-4-thiazolyl)-L-alanine is converted without protecting the aminothiazole group to the desired compound, as well as valuable intermediates used in the process.

Process For The Preparation Of [1S-(1R*,2S*3R*)]-N-(4-Morpholinylsulfonyl)-L-Phenylalanyl-3-(2-Amino-4- Thiazolyl-N-[(Cyclohexylmethyl)-2,3-Dihydroxy-5-Methylhexyl]-L-Alaninamid E

US Patent:
5220031, Jun 15, 1993
Filed:
Aug 21, 1991
Appl. No.:
7/748148
Inventors:
Daniel T. Belmont - Holland MI
Valerie Henderickson - Grandville MI
Mark J. Hoekman - Holland MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
C07D27740
US Classification:
548194
Abstract:
An improved process for the preparation of [1S-(1R*,2S*,3R*) ]-N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl)-N-[(1-c yclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-L-alaninamide is described where the key intermediate, 3-(2-amino-4-thiazolyl)-L-alanine is converted without protecting the aminothiazole group to the desired compound, as well as valuable intermediates used in the process.

Process For The Preparation Of An L-Alanine Compound

US Patent:
5268483, Dec 7, 1993
Filed:
Mar 11, 1993
Appl. No.:
8/029647
Inventors:
Daniel T. Belmont - Holland MI
Valerie Hendrickson - Grandville MI
Mark J. Hoekman - Holland MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
C07D27740
US Classification:
548194
Abstract:
An improved process for the preparation of [1S-(1R*,2S*,3R*)]-N (4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4 thiazolyl)-N-[(1-cyclohexylmethyl) -2,3-dihydroxy-5-methylhexyl]-L-alaninamide is described where the key intermediate, 3-(2-amino 4-thiazolyl)-L-alanine is converted without protecting the aminothiazole group to the desired compound, as well as valuable intermediates used in the process.

Possible Relatives

Dana M Belmont  Donna L Belmont  Elizabeth M Belmont  Gloria C Belmont  Jennifer V Belmont  John Belmont  Kathryn A Belmont  Daniel M Standish  Daniel K Standridge  Daniel C Stanfield 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.